EyePoint Pharmaceuticals, Inc. (EYPT) vs Vanda Pharmaceuticals Inc. (VNDA)
A side-by-side comparison of EyePoint Pharmaceuticals, Inc. and Vanda Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EYPT
EyePoint Pharmaceuticals, Inc.
$3.17HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
VNDA
Vanda Pharmaceuticals Inc.
$4.52HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — EYPT vs VNDA
growth of $100 · dividends reinvested · last 10yEYPT -89.5% (-20.2%/yr)VNDA -72.8% (-12.2%/yr)VNDA compounded faster over this window
EYPT VNDA
EYPT vs VNDA: by the numbers
- •VNDA is the larger company ($272M vs $266M market cap).
- •Both run net losses; VNDA's is the smaller (-127.41% vs -10994.73% net margin).
- •Both shrank revenue over the past five years; VNDA's decline was smaller (-3.56% vs -41.05% CAGR).
Metrics side by side
Valuation
| Metric | EYPT | VNDA |
|---|---|---|
| P/S ratio | 95.29 | 1.26 |
| P/B ratio | 1.60 | 1.23 |
Profitability
| Metric | EYPT | VNDA |
|---|---|---|
| Gross margin | 93.41% | 92.82% |
| Operating margin | -775.98% | -69.95% |
| Net margin | -10994.73% | -127.41% |
| ROE | -184.27% | -124.83% |
| ROIC | -170.19% | -74.73% |
Growth (annualized)
| Metric | EYPT | VNDA |
|---|---|---|
| Revenue CAGR (5Y) | -41.05% | -3.56% |
| Total return CAGR (5Y) | -21.68% | -23.91% |
Frequently asked
- Which has grown faster, EYPT or VNDA?
- Neither grew: over the past five years both shrank revenue, with VNDA's decline the smaller — EYPT at a -41.05% CAGR versus VNDA at -3.56%.
- How have EYPT and VNDA total returns compared?
- Over the past 10 years, EYPT delivered -20.02% and VNDA delivered -11.90% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.